The Latest

If Nobody Slashes the Price of Truvada for PrEP, What Happens Next?

Activists and doctors say they're ready to go further if Gilead won't agree to -- or the U.S. government won't force -- a price reduction to make PrEP accessible to more Americans who need it.

By Tim Murphy

How Activists Uncovered CDC's Ownership of Truvada PrEP Patents

The #PrEP4All campaign made the call for affordable pre-exposure prophylaxis a national news story.

By Charles Sanchez

Dovato Is a Newly Approved Two-Drug HIV Regimen. Do Fewer Drugs Mean a Lower-Cost HIV Treatment?

Advocates say the price is a step in the right direction. But does it go far enough?

By Tim Murphy

Sticker Shock: PrEP Is Not Cost-Effective at Current Price, Health Economists Find

But a survey reveals that about a third of black and Latino gay men would be willing to pay more than $50 per month for a prescription.

By Sony Salzman

Trump's Justice Department Just Declared All-Out War on Obamacare. What Does It Mean?

We answer some key questions about the latest new effort to kill the Affordable Care Act, including what it means for people living with HIV and what can do to make a difference.

By Tim Murphy

PrEP Pricing Is the Elephant in the Room at the CDC National HIV Prevention Conference

In a debate during a plenary session, Michael Saag, M.D., argued for more activism to make PrEP accessible to people who need it.

By Sony Salzman

What You Should Know About the House of Representatives' New "Medicare for All" Bill

Activist Mark Hannay explains what the bill means for people living with HIV and how it will shape the 2020 election debate.

By Tim Murphy

The Trump Administration's Drug Pricing Proposals for People With HIV, Explained

Drug pricing expert Tim Horn helps us make sense of the administration's future plans for the Medicare Part D and 340B programs.

By Tim Murphy

HIV Drug Prices Keep Rising. Why Is No One Talking About It?

In order to adequately address the HIV epidemic in the United States, two advocates argue that the high cost of antiretroviral drugs must be addressed.

By Christian Antonio Urrutia and James Krellenstein

With the House of Representatives Now in Democratic Hands, Here's What the Birddog Nation Activists Have Planned for Health Care in 2019

The activists have big plans for using their techniques to pressure the new Congress into inching toward universal health care in the years ahead.

By Tim Murphy